Breaking News
Upgrade 0
⭐ 📈 Which stocks do you need to beat the market in November?
See the list
Close

Finlabo Investments Sicav - Dynamic Us Equity R (0P0000O9BX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
79.090 -0.090    -0.11%
30/10 - Closed. Currency in EUR
Type:  Fund
Market:  Luxembourg
ISIN:  LU0507282266 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 3.12M
Finlabo Investments Sicav Dynamic US Equity R 79.090 -0.090 -0.11%

0P0000O9BX Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Finlabo Investments Sicav Dynamic US Equity R (0P0000O9BX) fund. Our Finlabo Investments Sicav Dynamic US Equity R portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 4.160 4.930 0.770
Shares 95.850 96.550 0.700

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 7.892 16.628
Price to Book 1.223 2.326
Price to Sales 0.505 1.608
Price to Cash Flow 3.967 10.570
Dividend Yield 2.546 2.336
5 Years Earnings Growth 9.047 11.474

Sector Allocation

Name  Net % Category Average
Healthcare 19.610 16.919
Consumer Defensive 13.520 5.576
Technology 13.350 16.047
Consumer Cyclical 12.030 14.256
Energy 11.300 6.478
Communication Services 8.960 9.784
Financial Services 6.380 13.048
Basic Materials 6.080 7.210
Industrials 5.030 15.279
Utilities 2.110 5.560
Real Estate 1.620 3.581

Region Allocation

  • North America
  • Latin America
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 181

Number of short holdings: 15

Name ISIN Weight % Last Change %
Nasdaq 100 E-Mini Futures Put 12/25 Cme 24500 - 1.09 - -
  Biogen US09062X1037 0.97 154.27 +3.11%
  Verizon US92343V1044 0.91 39.74 +2.00%
  IPG US4606901001 0.87 25.66 -0.19%
  Pfizer US7170811035 0.84 24.65 +1.48%
  Centene US15135B1017 0.83 35.37 +1.00%
  Treehouse Foods US89469A1043 0.81 18.20 +2.02%
  Hanesbrands US4103451021 0.79 6.610 -0.45%
  Bristol-Myers Squibb US1101221083 0.79 46.07 +0.99%
  IAMGold CA4509131088 0.79 16.24 -0.55%

Top Equity Funds by FinLabo SIM S.P.A.

  Name Rating Total Assets YTD% 3Y% 10Y%
  Global Managers Platform ING Addi 683.03M 4.30 8.30 4.41
  fLAB Fund S Core A 64.93M 2.33 4.91 2.70
  fLAB Fund SICAV Core B 64.93M 1.76 3.90 1.60
  ATOMO Glbl Flxbl R EUR Acc 29.15M 2.82 4.45 2.40
  ATOMO Glbl Flxbl I EUR Acc 29.15M 1.01 3.73 3.11
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000O9BX Comments

Write your thoughts about Finlabo Investments Sicav - Dynamic Us Equity R
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email